Decreased Serum Magnesium and Zinc Levels: Atherogenic Implications in Type-2 Diabetes Mellitus in Nigerians

Abstract

Serum magnesium, zinc and total cholesterol were evaluated in 40 Nigerian patients suffering from type-2 diabetes mellitus (2IM, 19F) and 20 (14M, 6F) apparently normal non diabetic control subjects. The mean age of the diabetic patients was similar to that of controls (p > 0.05). The mean duration of the disease was (4.7 + 0.7 SEM) in these patients. Fasting blood glucose and total cholesterol were significantly higher in diabetics than in non diabetic control subjects (p > 0.001). The serum total cholesterol showed inter-group variation when the patients were classified into four different age groups. In contrast, the serum level of magnesium (Mg) and zinc (Zn) were significantly lower in diabetics than in controls (p > 0.001). There were no significant correlation between glucose and the minerals, Mg. and Zn. Serum total cholesterol showed a significant positive correlation with magnesium (r = 0.6: p > 0.001), while the correlation with zinc was not significant.

In type-2 diabetic mellitus the concentration of both Mg and Zn levels were significantly reduced, probably suggesting lower antioxidant status in this condition. The implication is the greater susceptibility to LDL-cholesterol oxidation. The attendant risk of development of premature Coronary Heart Disease is discussed. Magnesium and zinc are nutritional minerals that play crucial roles in the regulation of carbohydrate and lipid metabolism.

Keywords

Antioxidants Glucose Cholesterol Atherogenicity Magnesium Zinc

Get full access to this article

View all access options for this article.

References

Unwin

Alberti

(2000). Primary health care interventions for non-communicable diseases. African Health, 22, 12–4.

McLarty

D.G.

Pollitt

Swai

A.B.M.

(1990). Diabetes in Africa. Diabetic Medicine, 7, 570–674.

Mosley

W.N.

Bobadella

J.L.

Jamison

D.T.

(1993). The health transition: Implication for health policy in developing countries. In: Jamison

D.T.

Mosley

W.N.

(Eds.) Disease Control Priorities in Developing Countries. Oxford University Press. New York.

WHO (World Health Organization) . (1997). The World Health Report 1997. Conquering suffering enriching humanity. World Health Organisation, Geneva.

Tolonen

(1990). Vitamins and minerals in health and nutrition. Ellis Horwood. New York, pp. 148–197.

Oberley

L.W.

(1988). Free radicals and diabetes. Free Radical Biol. 5, 113–24.

Wolf

(1993). Diabetes mellitus and free radical. Br. Med. Bull., 49, 642–652.

Jennings

P.E.

Chiraco

Jones

A.P.

et al. (1987). Vitamin C metabolites and Microangiopathy in diabetes mellitus. Diabetes Res. 6, 151–154.

Mooradian

A.D.

(1991). Increased serum conjugated dienes in elderly diabetic patients. J. Am. Ger. Soc. 39, 571–574.

10.

Abbe

M.R.

Truck

K.D.

(1994). Changes in pancreatic glutathione. Peroxidase and superoxide dismutase activities in the pre-diabetic prone BB rats. Proc. Soc. Exp. Biol. Med. 207, 206–212.

11.

Roza

A.M.

Pieper

G.M.

Johnston

C.P.

et al. (1995). Pancreatic antioxidant. Antioxidant enzyme activity in normo-glyceamic diabetes prone BB rats. Pancreas, 10, 53–58.

12.

Pidduck

H.G.

Wren

P.J.

Priced-Evans

D.A.

(1970). Hyperzincuria of DM and possible implication of this observation. Diabetes, 19, 240–247.

13.

Sjogren

Florence

Hilson

(1986). Magnesium deficiency in IDDM related to level of glycosylated hemoglobin. Diabetes, 35, 359–463.

14.

Trinder

(1969). Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann. Clin. Biochem. 6, 24.

15.

Allain

C.C.

Poon

L.S.

Chan

C.S.C.T.

Richard

P.C.

(1974). Enzymatic determination of total serum cholesterol. Clin. Chem. 20, 470.

16.

Hansen

Freier

E.F.

(1967). Determination of magnesium by atomic absorption spectrophotometer (AAS). Am. J. Med. Technol. 33, 158.

17.

Smith

J.C.

Butrimovitz

G.P.

Purdy

W.C.

(1979). Direct measurement of Zinc in plasma by atomic absorption spectrophometry. Clin. Chem. 125, 187.

18.

Ikkos

Luft

(1957). On the intravenous tolerance test. Acta Endocrinol. (Copenh), 25, 312–334.

19.

Leifebure

P.J.

Paolisio

Neludu

Castilo

M.J.

Scheen

A.J.

(1994). Magnesium and diabetes. Rev. Franc. Endocrinol. Clin. 35, 345–351.

20.

Suarez

Pulido

Casia

et al. (1993). Decreased insulin sensitivity in skeletal muscle of hypomagnesemic rats (abstract). Diabetologia, 36, A123.

21.

Geux

Cubizolles

Bussiere

Mazur

Ravssiguier

(1993). Oxidative modification of triglyceride rich lipoprotein in hypertriglyceridemic rats following magnesium deficiency. Lipids, 28, 573–5.

22.

Haenni

Ohrvall

Lithel

(1998). Atherogenic lipid fractions are related to ionized magnesium status. Am. J. Clin. Nutri. 67, 202–7.

23.

Yokoyama

Kashima

et al. (1994). Combined effects of magnesium deficiency and the atherogenic level of low density lipoprotein on uptake and metabolism of low density lipoprotein by cultured human endothelial cells. Magnes. Rec. 7, 97–105.

24.

Daniel

B.S.

William

B.C.

Lowacity

E.C.

Insulin like effects of zinc on adipocytes. Diabetes, 12, 127–135.

25.

Sjogren

Florence

C.H.

Hillson

(1998). Magnesium, potassium and zinc deficiency in subjects with type 2 diabetes mellitus. Acta Med. Scand. 224, 461–465.

26.

Smith

J.C.

McDaniel

E.G.

Fan

F.F.

et al. (1973). Zinc: a trace element essential in vitamin A metabolism. Science, 181, 954–5.

27.

Goode

H.F.

Purkins

Heady

R.V.

Kelleher

(1991). The effect of dietary vitamin deficiency on plasma zinc and copper concentrations. Clin. Nutri. 10, 233–235. And nutritional survey of British adults. Br. Med. J. 307, 1381–4.

28.

Steinberg

Parthasarthy

Carrew

J.E.

Kheo

J.C

Whltzturn

J.L.

(1989). Beyond cholesterol: modifications of low density lipoproteins that increase its atherogenicity. N. Eng. J. Med. 320, 915–24.

29.

Vilanova

Cuttierrez

Serrat

et al. (1997). Metalothionein zinc and copper levels: relationship with myocardial infarction. Clin. Biochem. 30, 235–238.

30.

Danbanchi

S.S.

Onyemelekwe

G.C.

(2000). Ischaemic heart disease in Nigerians: report of two cases. Diabetes International, 10, 59–60.

31.

Gulan-Abbas

Achibald

L.K.

(2000). Foot complications in diabetes with Symptomatic peripheral neuropathy in Dares Salaam, Tanzania. Diabetes International, 10, 52–55.

32.

Talabi

O.A.

(2000). Is hypokalaemia the killer in diabetic hyperosmolar states during treatment? Diabetes International, 10, 60–61.

33.

Muula

(2000). Preventing diabetes associates morbidity and mortality in resource poor communities. Diabetes International, 10, 47–8.

34.

Meyer

A.R.

Kush

L.H.

Jacob

D.R.

Jr. Sellers

J.A.

Folsom

AR.

(2000). Carbohydrate dietary fibre and incidence of type-2 diabetes in older women. Am. J. Clin. Nutr., 71, 921–30.

35.

McCarty

M.F.

(2000). Towards practical prevention of type-2 diabetes. Medical Hypothesis, 54, 786–93.

36.

Disilvestro

R.A.

(2000). Zinc in relation to diabetes and oxidative stress. J. Nutr., 130,1509S 1511S.